Q6PC93 AF NFT

Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidyamxrqgfggfsmrpqxrq7m7m3eattrvunpvgs67ssywls24ao2ty/metadata.json
IPFS of structure file: 
bafybeiecqo4yedx6bw35dzsghg2omffw5mn5d43xc7arb2hxuzl5hgunmi/AF-Q6PC93-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x9F605311B7e26e76340423EfAfbE5e2EFc7A0b7C
First NFT owner address (bech32): 
genesis1nas9xydhufh8vdqyy0h6l0j79m785zmurgry0u
Current NFT ID #266318 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
266318
Accession (UniProt):
Q6PC93
Name::
Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2
Experimental Method:
Predicted structure
Sequence source:
DANIO RERIO

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q6PC93 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q6PC93|NMNA2_DANRE Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 OS=Danio rerio OX=7955 GN=nmnat2 PE=2 SV=1 MTENTKTHVILLSCGSFNPITKGHIHMFEKAREYLHKTGRFIVIGGIVSPVHDSYGKPGLVPSRHRLTMCQLAVQSSDWIRVDPWECYQDTWQTTCSVLEHHRDLMKRVTGCILSNVNTPSTTPVIGQPQNETSAIYQNTVNKSVAIKFWGKMSESLGKICCVRPHMDRFTFVDENANLGTAMRYEEIELRILLLCGSDLLESFCIPGLWNESDMEVIVGDFGIVVVPRDGADTERIMNHSSVLRKHKDNIIVVKDEIDHPMSIVSSTKSRLALQHGDGHVVDYLSQPVIDYILQSQLYINASG